Aurora Cannabis Inc. (ACB)
Aurora Cannabis Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Edmonton, AB, CA. The stock last traded at $3.78, up 8.53% on the session, giving a market capitalisation of $234.3M. On trailing twelve-month figures it carries a trailing P/E of -2.73, a net margin of -38.2%. Its beta of 1.34 implies it has historically moved more than the broad market.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Aurora Cannabis Inc. is most often compared with the following Healthcare names: